Join us for a LIVE, interactive broadcast on NSCLC Friday 10/5 – sign up today to be reminded to tune in!

Look Who's Making Cancer Screening Recommendations

Monday, February 04, 2013
The print and online Consumer Reports (also available in Spanish) is a well-recognized source of information and guidance for consumers. Consumers typically use Consumer Reports ratings when making purchasing decisions for things like cars and appliances. Now, for the first time (March 2013 issue), Consumer Reports has issued its ratings of cancer screening tests.

Healthcare providers need to be aware of these recommendations, as it is likely that patients and the public will be asking questions about them, and possibly utilizing them when making decisions to undergo, or forego, cancer screening. The Consumer Reports recommendations are based on evidence-based reviews from the U.S. Preventive Services Task Force (USPSTF). USPSTF, an independent panel of experts appointed by the U.S. Department of Health and Human Services. The USPSTF recommendations target healthcare providers while the Consumer Reports recommendations target the public.

To help clarify when consumers should use cancer screenings and when they should skip them, Consumer Reports rated each screening test and its usefulness for different age groups. Screening for cervical cancer received Consumer Reports' highest score, and is recommended for women age 21-65. Colon cancer screening received the top score for people ages 50-75, but screening is less valuable for people ages 76-85 and least valuable for those ages 86 and older and age 49 and younger. Consumer Reports recommends screening for breast cancer for women 50-74, and women in their 40s or those ages 75 and older are advised to consult their healthcare providers to determine if the benefits outweigh the harm based on their individual breast cancer risk factors. Screening tests for bladder, lung, skin, oral, prostate, ovarian, pancreatic and testicular cancers are not recommended by Consumer Reports, which makes sense since evidence of their efficacy is lacking.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.